T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Invesco DB Commodity Index Tracking Fund
DBC
$1.71B
| $948K | ﹤0.01% |
+51,360
| New | +$1.09M |
|
|
TGI
1727
DELISTED
Triumph Group
TGI
| $948K | ﹤0.01% |
14,100
-2,500
| -15% | -$164K |
|
|
CVA
1728
DELISTED
Covanta Holding Corporation
CVA
| $944K | ﹤0.01% |
42,904
-10,300
| -19% | -$232K |
|
1729
Civeo
CVEO
$344M
| $938K | ﹤0.01% |
19,017
-2,841
| -13% | -$353K |
|
|
GRT
1730
DELISTED
GLIMCHER REALTY TRUST
GRT
| $937K | ﹤0.01% |
68,160
-5,200
| -7% | -$71.1K |
|
|
AMSG
1731
DELISTED
Amsurg Corp
AMSG
| $936K | ﹤0.01% |
17,100
| – | – |
|
1732
Winnebago Industries
WGO
$921M
| $932K | ﹤0.01% |
42,820
-2,770,590
| -98% | -$63.5M |
|
1733
Sensient Technologies
SXT
$5.53B
| $928K | ﹤0.01% |
15,380
| – | – |
|
1734
Dolby
DLB
$5.84B
| $926K | ﹤0.01% |
21,482
-1,567,758
| -99% | -$66.6M |
|
|
PFC
1735
DELISTED
Premier Financial Corp. Common Stock
PFC
| $925K | ﹤0.01% |
54,344
-1,800
| -3% | -$27.3K |
|
|
IRF
1736
DELISTED
INTL RECTIFIER CORP
IRF
| $918K | ﹤0.01% |
23,020
+2,700
| +13% | +$107K |
|
1737
Invesco Mortgage Capital
IVR
$805M
| $917K | ﹤0.01% |
5,930
-460
| -7% | -$74.3K |
|
|
SJI
1738
DELISTED
South Jersey Industries, Inc.
SJI
| $915K | ﹤0.01% |
31,040
+3,400
| +12% | +$97.2K |
|
1739
Charles River Laboratories
CRL
$13.4B
| $912K | ﹤0.01% |
14,327
+266
| +2% | +$16.7K |
|
1740
MGE Energy Inc
MGEE
$3.06B
| $901K | ﹤0.01% |
19,750
| – | – |
|
1741
Timken Company
TKR
$9.1B
| $896K | ﹤0.01% |
21,000
| – | – |
|
1742
ONE Gas
OGS
$5.09B
| $894K | ﹤0.01% |
21,700
-78,092
| -78% | -$3.03M |
|
|
CVG
1743
DELISTED
Convergys
CVG
| $894K | ﹤0.01% |
43,900
| – | – |
|
|
APOL
1744
DELISTED
Apollo Education Group Inc Class A
APOL
| $888K | ﹤0.01% |
26,040
+180
| +0.7% | +$5.3K |
|
1745
Fair Isaac
FICO
$24B
| $881K | ﹤0.01% |
12,181
| – | – |
|
1746
Webster Financial
WBS
$12.8B
| $875K | ﹤0.01% |
26,913
| – | – |
|
1747
Regal Rexnord
RRX
$11.4B
| $872K | ﹤0.01% |
11,600
| – | – |
|
1748
Forward Air
FWRD
$682M
| $868K | ﹤0.01% |
17,235
| – | – |
|
1749
Dana Inc
DAN
$3.26B
| $867K | ﹤0.01% |
39,860
-72,440
| -65% | -$1.46M |
|
|
TIVO
1750
DELISTED
Tivo Inc
TIVO
| $866K | ﹤0.01% |
38,333
-5,200
| -12% | -$109K |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.